Exploring Boscia senegalensis-Derived Boscisucrophage: A Novel Dual SGLT1 and SGLT2 Inhibitor Enhancing Glycemic Control in Oral Drug-Resistant Type 2 Diabetes Patients: Insights from a Preliminary Observational Cohort Study
How to cite: Eto, B.; Miantezila Basilua, J.; Outman, A.; Ndjip, R. C.; Alqahtani, A. S.; Bourhim, M.; Ibet, B.; Ramadam, I.; Torina, C.; Pagui, P.; Tchalkoutou, K.; Mahamat, N.; Cordier, J.; Gressier, B.; Desjeux, J.-F. Exploring Boscia senegalensis-Derived Boscisucrophage: A Novel Dual SGLT1 and SGLT2 Inhibitor Enhancing Glycemic Control in Oral Drug-Resistant Type 2 Diabetes Patients: Insights from a Preliminary Observational Cohort Study. Preprints 2024, 2024081121. https://doi.org/10.20944/preprints202408.1121.v1 Eto, B.; Miantezila Basilua, J.; Outman, A.; Ndjip, R. C.; Alqahtani, A. S.; Bourhim, M.; Ibet, B.; Ramadam, I.; Torina, C.; Pagui, P.; Tchalkoutou, K.; Mahamat, N.; Cordier, J.; Gressier, B.; Desjeux, J.-F. Exploring Boscia senegalensis-Derived Boscisucrophage: A Novel Dual SGLT1 and SGLT2 Inhibitor Enhancing Glycemic Control in Oral Drug-Resistant Type 2 Diabetes Patients: Insights from a Preliminary Observational Cohort Study. Preprints 2024, 2024081121. https://doi.org/10.20944/preprints202408.1121.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)